Lifting coronavirus restrictions: The role of therapeutics, testing, and contact-tracing apps
The key to tackling the coronavirus pandemic is a combination of safe and readily available vaccines that provide everyone with immunity, as well as effective treatments that work to cure the disease in all infected people.
Written by Costica Dumbrava,
The key to tackling the coronavirus pandemic is a combination of safe and readily available vaccines that provide everyone with immunity, as well as effective treatments that work to cure the disease in all infected people. Short of this, the ongoing public health crisis requires a mix of non-pharmaceutical measures aimed at reducing the spread of the virus, including identifying and isolating cases, testing, contact tracing and broader containment measures.
With the number of Covid-19 cases in the EU falling steadily since the beginning of May, most Member States have begun to ease restrictions on free movement and social gatherings. However, lifting restrictions in the absence of vaccines and treatments requires enhanced monitoring measures, such as an expanded testing capacity and improved contact tracing, including through the use of appropriate digital technologies.
There is the hope that the impressive mobilisation of resources and expertise will soon lead to breakthroughs in the quest for safe vaccines and effective treatments for Covid-19. However, it may take a while before such therapeutics are made available to everyone that needs them. Beyond dealing with challenges relating to scientific knowledge and a cumbersome development process, there is a need to address questions regarding mass manufacturing and fair distribution. Given the uncertainties and challenges associated with Covid-19 therapeutics, it may be wise to moderate expectations in order to foster resilience and preserve public trust.
Expanding testing capacity and updating testing strategies to support disease monitoring at population level is crucial for minimising the risk of new outbreaks in the context of relaxing containment measures. Using antibody tests to monitor the disease is a promising avenue, though more evidence is needed to demonstrate the reliability of these tests, in particular given current knowledge gaps regarding people’s immunity to the virus. Moreover, linking antibody testing to relaxing restrictions for individuals, as suggested by the idea of establishing ‘immunity passports’, raises additional concerns about non-discrimination, fairness and mass surveillance.
Together with identifying and isolating new cases (through testing), the rapid and efficient tracing of people who have recently been in contact with infected people is essential for reducing the spread of the virus. Automating, at least partially, the laborious task of contact tracing with the help of contact-tracing apps has been advocated as a key measure to enable the gradual lifting of restrictions. The ongoing debate on contact-tracing apps in the EU seems to be converging towards a preference for voluntary contact-tracing apps that rely on proximity/bluetooth data (as opposed to location data) and comply with EU rules on data protection and privacy. The debate continues on the specific technical design of such apps (e.g. centralised versus decentralised systems), though the majority of initiatives in Member States seem to rely on decentralised systems. There are nevertheless a number of open questions regarding contact-tracing apps, in particular on their reliability, usability, data protection and privacy, epidemiological value and broader social implications.
There are very few certainties regarding the Covid-19 pandemic, but perhaps one certainty is that no isolated measure or silver-bullet solution is likely to solve all aspects of the crisis. A flexible and integrated strategy, in terms of complementary tools and measures, as well as a coordinated approach across the EU, will be crucial in enabling the gradual lifting of restrictions and a return to the (new) normal.
Read the complete in-depth analysis on ‘Lifting coronavirus restrictions: The role of therapeutics, testing, and contact-tracing apps‘ in the Think Tank pages of the European Parliament.
The central task of the Members Research Service is to ensure that all Members of the European Parliament are provided with analysis of, and research on, policy issues relating to the European Union, in order to assist them in their parliamentary work.
Combating corruption in the European Union
2024 European elections: National rules
Plant reproductive material [EU Legislation in Progress]
Relations ahead of the 24th EU-China summit
EU-New Zealand free trade agreement – One step closer to ratification [International Agreements in Progress][Policy Podcast]
What if the EU was energy independent? [Science and Technology Podcast]
BEFIT – Business in Europe: Framework for income taxation [EU Legislation in Progress]
Continuation of the Partnership for Research and Innovation in the Mediterranean Area [EU Legislation in Progress]
CO2 emissions of new cars and vans
Youth participation in European elections
Circularity requirements for vehicle design and management of end-of-life vehicles [EU Legislation in Progress]
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
The present website is hosted by WordPress.com, a service by Automattic. Automattic is a global company with thousands of servers located in several separate data centres around the world. While Automattic takes care of the security of the platform, we, the European Parliamentary Research Service, own the content of the blog. For more detailed information about the compliance of Automattic products and services with the EU General Data Protection Regulation (GDPR), please see their dedicated page.
We do not collect any personal data that could identify an individual user. The users that are registered in WordPress.com should consult wordpress.com terms of service. We do collect anonymised aggregate data for statistical purposes. The data collected for this purposes include: number of visits/visitors per page, the country of the user, and aggregate numbers of incoming and outgoing clicks.
We determine unique page counts by using a “hashed” version of the visitor’s IP address. The visitor’s full IP address is deleted from our logs after a little over a month. That timeframe is how long the data is needed in order to allow us to calculate your stats on a monthly basis and no longer.
We collect your email address only if you proactively requested to be notified about the updates on the blog. You can always contact us to remove your email address from our records or unsubscribe from the notification service.
We can also see your name and email address if you made a comment to one of our posts. We do not make the email address visible on the comment. Nevertheless, on request, we can delete your comments.
We collect cookies only to facilitate your browsing experience, such as enabling you to share our posts via social media or comment on the post. The majority of cookies will be used only if you are a registered WordPress.com user. In this case, you are bound to WordPress.com terms of service.
Some pages embed content from third parties. In this case, you will need to actively consent to their terms in order to see the content.